Imfinzi Adds Approval In Early-Stage Lung Cancer, Matching Keytruda

AZN
AstraZeneca adds early-stage lung cancer perioperative indication to Imfinzi's label • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from New Products

More from Scrip